SLFN11 and pachyonychia congenita: Within the scope of personalized medicine, the Schlafen Family Member-11 (SLFN11) protein was found to be a proteomic biomarker associated with platinum chemotherapy response in patients with castration-resistant PC, where patient-derived PC organoids with SLFN1 knockout did not respond to cisplatin at deadly concentrations [78].